Trials / Unknown
UnknownNCT00622934
Relationship Between Erythropoietin Administration and Stress Responses in Trauma Patients
Relationship Between Clinical Recovery and Oxidative Stress and Inflammation Following Usage of Erythropoietin in Admitted Traumatic Patient In Intensive Care Unit
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Tehran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Erythropoietin decrease stress responses and inflammation in trauma patient.
Detailed description
Transfusion of blood products has many disadvantages. Erythropoietin is used to increase red blood cells production and decrease such disadvantages.In some studies anti inflammatory effects is shown for Erythropoietin. One of the most problems in the intensive care unit is stress response. we are going to evaluate effects of erythropoietin on oxidative stress and inflammation in trauma patient in intensive care unit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | erythropoietin | 300mg/kg erythropoietin 3 times on the first week of admission |
| DRUG | placebo | placebo |
Timeline
- Start date
- 2007-07-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2008-02-25
- Last updated
- 2010-11-18
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT00622934. Inclusion in this directory is not an endorsement.